Lescarden (LCAR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lescarden (LCAR)

LCAR 0.00

Mar 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Harry Chmelynski who wrote ()	2/29/2000 7:27:00 PM
From: SgtPepper	of 3

Info from Raging Bull. Looks like a Promising Company! It seems that the company is marketing the bovine material as a wound healer which is smart if they want some profits. Phase II clinical trials will bring some attention. I looked over their website and I see they are trying to get the bovine cartilage to be used for tumors. The results for the arthritis glucosamine thing are not due till fall....The clinical trials need to go through phase three also before they can apply for FDA approval. They have a cosmetic wound healer out now. Biotech is hot! Looks from the chart that it is on an uptrend . An arthritis cure would be huge. Bovine Cartilage works in the treatment of some cancers and is extremely plentiful.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext